Cite

    Pierot, L., Spelle, L., Berge, J., Januel, A., Herbreteau, D., Aggour, M., Piotin, M., Biondi, A., Barreau, X., Mounayer, C., Papagiannaki, C., Lejeune, J., Gauvrit, J., & Costalat, V. (2018). feasibility, complications, morbidity, and mortality results at 6 months for aneurysm treatment with the Flow Re-Direction Endoluminal Device: report of SAFE study. Journal of neurointerventional surgery, 10, 765–770. http://access.bl.uk/ark:/81055/vdc_100136716730.0x00000f